FSIGT
Showing 1 - 25 of 36
Obesity, Diabetes Type 2 Trial in Lancaster (Semaglutide Pen Injector [Ozempic])
Recruiting
- Obesity
- Diabetes Type 2
- Semaglutide Pen Injector [Ozempic]
-
Lancaster, PennsylvaniaAmish Research Clinic
Jul 29, 2022
Type 2 Diabetes Trial in Lancaster (Exenatide Injection, Saline injection)
Terminated
- Type 2 Diabetes
- Exenatide Injection
- Saline injection
-
Lancaster, PennsylvaniaAmish Research Clinic
Mar 6, 2023
Type 1 Diabetes Trial in San Francisco (Co-transplantation of PTG with pancreatic islets)
Recruiting
- Type 1 Diabetes
- Co-transplantation of PTG with pancreatic islets
-
San Francisco, CaliforniaUniversity of California
Jul 7, 2022
Insulin Resistance, Obesity Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Placebo,
Not yet recruiting
- Insulin Resistance
- Obesity
- Placebo
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 10, 2023
Obesity Trial in Philadelphia (Eating Condition)
Active, not recruiting
- Obesity
- Eating Condition
-
Philadelphia, PennsylvaniaCenter for Weight and Eating Disorders, Perelman School of Medic
Nov 8, 2022
Kidney Transplant, Type 1 Diabetes Trial in Boston (Alpha 1-Antitrypsin, Islet Transplantation, Thymoglobulin)
Active, not recruiting
- Kidney Transplant
- Type 1 Diabetes
- Alpha 1-Antitrypsin
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital
Nov 15, 2021
Insulin Resistance, Type 2 Diabetes, Metabolic Syndrome Trial in Berkeley, San Francisco (Diet)
Completed
- Insulin Resistance
- +4 more
- Diet
-
Berkeley, California
- +1 more
Dec 22, 2020
Diabetes, Type I Trial in Oslo, Stockholm, Uppsala (Low Molecular Weight Sulfated Dextran (LMW-SD), Heparin, CellCept®
Completed
- Diabetes Mellitus, Type I
- Low Molecular Weight Sulfated Dextran (LMW-SD)
- +8 more
-
Oslo, Norway
- +2 more
Sep 22, 2021
Type 1 Diabetes Trial in Columbus (Human Pancreatic Islets)
Active, not recruiting
- Type 1 Diabetes
- Human Pancreatic Islets
-
Columbus, OhioThe Ohio State University Medical Center
Oct 26, 2021
Mapping Genes for Type 2 Diabetes Mellitus
Completed
- Genetic Variation
- Diabetes
-
Helsinki, Finland
- +3 more
May 22, 2020
Type 1 Diabetes Trial in Canada, United States (biological, drug, procedure)
Completed
- Type 1 Diabetes Mellitus
- Allogeneic Pancreatic Islet Cells
- +6 more
-
San Francisco, California
- +7 more
Jul 11, 2019
Type 2 Diabetes Trial in Copenhagen (Carbohydrate-Restricted Diet, Standard Antidiabetic Diet)
Completed
- Type 2 Diabetes Mellitus
- Carbohydrate-Restricted Diet
- Standard Antidiabetic Diet
-
Copenhagen, Copenhagen NV, DenmarkBispebjerg Hospital
Mar 1, 2018
Coronary Artery Disease, Glucose Intolerance Trial in Hamilton (Exercise training)
Completed
- Coronary Artery Disease
- Glucose Intolerance
- Exercise training
-
Hamilton, Ontario, CanadaHamilton Health Sciences Centre
Aug 25, 2017
Metabolic Syndrome, Insulin Resistance, Prediabetes Trial in Little Rock, Lexington (Pioglitazone)
Completed
- Metabolic Syndrome
- +2 more
-
Little Rock, Arkansas
- +1 more
May 24, 2017
Type 1 Diabetes Trial in Canada, United States (Islet transplantation, Antithymocyte Globulin, Daclizumab or Basiliximab)
Completed
- Type 1 Diabetes Mellitus
- Islet transplantation
- +4 more
-
San Francisco, California
- +9 more
Oct 18, 2017
Metabolic Syndrome X Trial in Boston (Etanercept, Placebo)
Completed
- Metabolic Syndrome X
- Etanercept
- Placebo
-
Boston, MassachusettsMass General Hospital
Oct 4, 2017
Coronary Artery Disease, Diabetes, Type 2 Trial in Copenhagen (Liraglutide, Placebo)
Completed
- Coronary Artery Disease
- Diabetes Mellitus, Type 2
- Liraglutide
- Placebo
-
Copenhagen, Bispebjerg, DenmarkCopenhagen University Hospital, Bispebjerg
Mar 4, 2017
Insulin Resistance Atherosclerosis Study (IRAS)
Completed
- Cardiovascular Diseases
- +5 more
- (no location specified)
Aug 5, 2016
Type 1 Diabetes Trial in Atlanta, Edmonton (biological, drug, procedure)
Completed
- Type 1 Diabetes Mellitus
- Allogeneic Pancreatic Islet Cells
- +5 more
-
Atlanta, Georgia
- +1 more
Mar 9, 2016
Lead to a Sustained Increase in Insulin Sensitivity?
Completed
- Overweight and Obesity
- Insulin Sensitivity
-
Adelaide, South Australia, AustraliaHyperbaric Medicine Unit, Royal Adelaide Hospital
Nov 30, 2015
Diabetes, Type 1 Trial in San Francisco, Chicago, Minneapolis (Allogeneic Pancreatic Islet Cells, Deoxyspergualin, Antithymocyte
Completed
- Diabetes Mellitus, Type 1
- Allogeneic Pancreatic Islet Cells
- +6 more
-
San Francisco, California
- +2 more
Feb 17, 2016
T2DM in the Youth- a Study of the Malaysian Population
Completed
- Diabetes Mellitus, Type 2
- OGTT and IVGTT tests
-
Penang, MalaysiaPenang Medical College
Jul 23, 2016
Meta-analyses of Fructose and Cardiometabolic Risk
Unknown status
- Dyslipidemia
- +10 more
- Dietary fructose
-
Toronto, Ontario, CanadaThe Toronto 3D (Diet, Digestive tract and Disease) Knowledge Syn
May 26, 2015
Hypertension, Abdominal Obesity Trial in Berlin-Buch, Hannover (Aliskiren, Amlodipine, Placebo of Aliskiren)
Terminated
- Hypertension
- Abdominal Obesity
- Aliskiren
- +3 more
-
Berlin-Buch, Germany
- +1 more
Sep 9, 2014